Owners, management and financials
CVR: 44512971
DKK -2,230,382
Gross profit
Net result: DKK -4,245,453
Copenhagen Equity ApS (25-33,32%), North2k ApS (25-33,32%)
2 more
CVR · view owners
Torben Hald, Anders Miki Bojesen
2 more in management
Board: Anders Miki Bojesen (chair) and 3 members
CVR · view management
Active
Founded 19 December 2023
CVR · view overview
6 employees
CVR · 2026
Director registered: Thomas Frees Buthler
CVR · 27/01/2025
View the full event history
Gefjon Pharma ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Torben Hald, Anders Miki Bojesen and Fabio Antenucci. The board consists of Anders Miki Bojesen (chair), Fabio Antenucci, Thomas Frees Buthler and Torben Hald. The company's owners include Copenhagen Equity ApS, North2k ApS and TBU Holding 2023 ApS. The company has 6 employees (2026). In 2026, the company reported a gross profit of DKK -2,230,382 and a net result of DKK -4,245,453. Equity in the 2026 report amounted to DKK -4,998,334.
Selskabets formål er at drive virksomhed med udvikling, produktion og salg af lægemidler til levnedsmiddelindustrien samt enhver anden aktivitet, som efter ledelsens skøn står i forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/04/2025 – 31/03/2026 | -2.2 mio. | -4.2 mio. | 7.9 mio. | -5 mio. | 5 |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Gefjon Pharma ApS is 44512971.
The owners of Gefjon Pharma ApS include Copenhagen Equity ApS, North2k ApS and TBU Holding 2023 ApS.
The management of Gefjon Pharma ApS consists of Torben Hald, Anders Miki Bojesen and Fabio Antenucci.
The board of Gefjon Pharma ApS consists of Anders Miki Bojesen, Fabio Antenucci and Thomas Frees Buthler, with Anders Miki Bojesen as chair.
In 2026, Gefjon Pharma ApS reported a gross profit of DKK -2,230,382.
Gefjon Pharma ApS had 6 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Gefjon Pharma ApS has published its annual report for 2026. Gross profit came to DKK -2,230,382, and the net result was DKK -4,245,453.
Contact info changed: new phone: 50899528, new email: [email protected], new website: www.gefjonpharma.com (June 12, 2026).
As of June 10, 2026, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Gefjon Pharma ApS.
Contact info changed: new phone: 50899528, new email: [email protected], new website: www.gefjonpharma.com (February 4, 2026).
As of February 3, 2026, Thomas Frees Buthler has joined the board of directors of Gefjon Pharma ApS.
As of February 3, 2026, Anders Miki Bojesen has joined the board of directors of Gefjon Pharma ApS.
As of February 3, 2026, Torben Hald has joined the board of directors of Gefjon Pharma ApS.
As of February 3, 2026, Fabio Antenucci has joined the board of directors of Gefjon Pharma ApS.
Gefjon Pharma ApS has published its interim report for the period December 19, 2023 to March 31, 2025.
As of January 27, 2025, Thomas Frees Buthler is registered as director of Gefjon Pharma ApS.
As of January 27, 2025, Anders Miki Bojesen is registered as director of Gefjon Pharma ApS.
As of January 27, 2025, Fabio Antenucci is registered as director of Gefjon Pharma ApS.
As of September 23, 2024, Thomas Frees Buthler has stepped down as director of Gefjon Pharma ApS.
As of September 1, 2024, Torben Hald is registered as adm. dir. of Gefjon Pharma ApS.
As of December 19, 2023, Thomas Frees Buthler is registered as director of Gefjon Pharma ApS.
As of December 19, 2023, Copenhagen Equity ApS is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
As of December 19, 2023, North2k ApS is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
As of December 19, 2023, TBU Holding 2023 ApS is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
As of December 19, 2023, is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
Gefjon Pharma ApS was founded on December 19, 2023.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
